Search results for "Case-Control Studies"

showing 10 items of 1567 documents

BRCA1 promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancer

2019

Methylation of the promoter of the BRCA1 gene in DNA derived from peripheral blood cells is a possible risk factor for breast cancer. It is not clear if this association is restricted to certain types of breast cancer or is a general phenomenon. We evaluated BRCA1 methylation status in peripheral blood cells from 942 breast cancer patients and from 500 controls. We also assessed methylation status in 262 paraffin‐embedded breast cancer tissues. Methylation status was assessed using methylation‐sensitive high‐resolution melting and was categorized as positive or negative. BRCA1 methylation in peripheral blood cells was strongly associated with the risk of triple‐negative breast cancer (TNBC)…

AdultOncologyCancer Researchmedicine.medical_specialtyConcordanceTriple Negative Breast Neoplasms03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBreast cancerInternal medicineBiomarkers TumormedicineHumansGenetic Predisposition to DiseaseBreastRisk factorPromoter Regions Geneticskin and connective tissue diseasesTriple-negative breast cancerAgedAged 80 and overBRCA1 Proteinbusiness.industryMethylationOdds ratioDNA MethylationMiddle Agedmedicine.diseaseOncologychemistryCase-Control Studies030220 oncology & carcinogenesisBiomarker (medicine)FemalebusinessDNAFollow-Up StudiesInternational Journal of Cancer
researchProduct

Antibody microarray analysis of the serum proteome in primary breast cancer patients

2011

Noninvasive biomarkers are urgently needed for detecting breast cancer as early as possible since the risk of recurrence, morbidity, and mortality is closely related to disease stage at the time of primary surgery. There are currently no such biomarkers in clinical use as a diagnostic tool. Proteomic analysis of protein expression patterns in body fluids has potential for use in identifying biomarkers of breast cancer. The aim of this study was to compare protein expression levels in the sera of primary breast cancer patients and healthy controls. An antibody microarray tool with 23 antibodies immobilized on nitrocellulose slides was used to determine the levels of acute phase proteins, int…

AdultOncologyCancer Researchmedicine.medical_specialtyProteomeAntibody microarrayProtein Array AnalysisBreast NeoplasmsDiseaseBreast cancerInternal medicineBiomarkers TumorHumansMedicineStage (cooking)AgedAged 80 and overImmunoassayPharmacologybiologybusiness.industryAcute-phase proteinInterleukinMiddle Agedmedicine.diseaseOncologyCase-Control StudiesImmunologybiology.proteinMolecular MedicineFemaleNeoplasm GradingAntibodybusinessPrimary breast cancerCancer Biology & Therapy
researchProduct

Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection

2019

Objective: Persistent high-risk HPV (HR HPV) infection leads to the development of squamous intraepithelial lesions, which in turn may progress to cervical cancer. Telomere elongation or shortening may indicate a carcinogenesis process. In the present study, we analyzed telomere length from blood and cervical smears of women without and with high-risk HPV infection. Materials and methods: Telomere length was quantified by real-time PCR in blood and cervical smears from 48 women with high-risk HPV infection and HGSIL or LGSIL, 29 women HR-HPV positive without SIL, and 11 HPV-negative women. Results: No correlation was found between age and telomere length in blood and cervical smears. Women …

AdultOncologyHuman papillomavirusmedicine.medical_specialtyUterine Cervical NeoplasmsCervix Uterimedicine.disease_causelcsh:Gynecology and obstetricsRisk Assessment03 medical and health sciences0302 clinical medicineInternal medicineLeukocytesHumansMedicineHuman papillomavirusPapillomaviridaelcsh:RG1-991Early Detection of CancerVaginal SmearsCervical cancer030219 obstetrics & reproductive medicinebusiness.industryPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and GynecologyCervical cellsLeukocyteTelomeremedicine.diseaseCervical smearsfemale genital diseases and pregnancy complicationsTelomereCervical smearCase-Control StudiesFemalebusinessCarcinogenesisTelomere elongationPapanicolaou TestTaiwanese Journal of Obstetrics and Gynecology
researchProduct

Autoantibodies in breast cancer: their use as an aid to early diagnosis

2007

There is increasing evidence that the immune system produces a humoral response to cancer-derived antigens. This study assessed the diagnostic potential of autoantibodies to multiple known tumour-associated proteins.Sera from normal controls (n = 94), primary breast cancer patients (n = 97) and patients with ductal carcinoma in situ (DCIS) (n = 40) were investigated for the presence of autoantibodies to p53, c-myc, HER2, NY-ESO-1, BRCA1, BRCA2 and MUC1 antigens by enzyme-linked immunosorbent assay.Reproducibly elevated levels of autoantibodies were seen in at least one of the six antigens in 64% of primary breast cancer patient sera and 45% of patients with DCIS at a specificity of 85%. No …

AdultOncologyPathologymedicine.medical_specialtyAntibodies NeoplasmBreast NeoplasmsEnzyme-Linked Immunosorbent Assaymedicine.disease_causeSensitivity and SpecificityAutoimmunityCohort StudiesBreast cancerAntigenAntigens NeoplasmInternal medicinemedicineHumansMammographyNeoplasm Metastasisskin and connective tissue diseasesLymph nodeAgedAutoantibodiesAged 80 and overmedicine.diagnostic_testbusiness.industryAutoantibodyReproducibility of ResultsCancerHematologyMiddle Agedmedicine.diseaseCarcinoma LobularCarcinoma Intraductal NoninfiltratingEarly Diagnosismedicine.anatomical_structureIncreased riskReceptors EstrogenOncologyCase-Control StudiesFemalebusinessAnnals of Oncology
researchProduct

Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer

2020

Importance Persistent chemotherapy-induced alopecia (pCIA) has been recently described in patients with breast cancer and in its most severe form occurs in up to 10% of these patients. Genetic risk factors associated with pCIA have not been adequately explored. Objective To identify genetic variants associated with pCIA. Design, Setting, and Participants In this genetic association study, 215 women with breast cancer treated with docetaxel-based chemotherapy with a follow-up of 1.5 to 10 years after the end of the treatment were recruited retrospectively through 3 hospital oncology units across Spain between 2005 and 2018. Severe pCIA was defined as lack of scalp hair recovery (Common Termi…

AdultOncologymedicine.medical_specialtyATP Binding Cassette Transporter Subfamily BBiopsyBreast NeoplasmsGenome-wide association studyDocetaxelDermatologyPolymorphism Single Nucleotide030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBreast cancerRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansGenetic Predisposition to DiseasePromoter Regions GeneticAdverse effectRetrospective StudiesDose-Response Relationship Drugbusiness.industryAge FactorsCase-control studyAlopeciaCommon Terminology Criteria for Adverse EventsRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseEnhancer Elements GeneticDocetaxelCase-Control Studies030220 oncology & carcinogenesisFemalebusinessHair FollicleFollow-Up StudiesGenome-Wide Association Studymedicine.drugJAMA Dermatology
researchProduct

Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer

2003

The chemokine monocyte chemoattractant protein (MCP)-1 is thought to be involved in breast carcinogenesis. We evaluated MCP-1 serum levels in patients with breast cancer (n = 135), ductal carcinoma in situ (DCIS) I-III (n = 30), benign breast lesions (n = 143) and in healthy women (n = 27). We determined the value of MCP-1 serum levels as a differentiation marker between malignant, preinvasive and benign breast diseases and as a predictive marker for the biological phenotype of breast carcinoma. Median (range) MCP-1 serum levels in patients with breast cancer, DCIS I-III, benign breast lesions and healthy women were 200 (57-692) pg/ml, 194 (58-525) pg/ml, 174 (39-529) pg/ml and 175 (67-425)…

AdultOncologymedicine.medical_specialtyCA 15-3Breast NeoplasmsBreast DiseasesBreast cancerReference ValuesInternal medicineBiomarkers TumormedicineCarcinomaHumansNeoplasm Invasivenessskin and connective tissue diseasesLymph nodeChemokine CCL2AgedRetrospective StudiesPredictive markerbusiness.industryCase-control studyGeneral MedicineMiddle AgedDuctal carcinomamedicine.diseaseCarcinoma Intraductal NoninfiltratingCell Transformation NeoplasticPhenotypemedicine.anatomical_structureCase-Control StudiesLymphatic MetastasisFemaleBreast carcinomabusinessTumor Biology
researchProduct

p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer

2011

Abstract Objective P53 tumor suppressor gene plays a role in endometrial carcinogenesis. Former studies described correlations between p53 protein overexpression in endometrial cancer and prognostic factors, measured by immunohistochemistry. But data is still controversial. The aim of this study was to measure p53 and phospho-p53 overexpression by Western blot and evaluate correlations between overexpression and prognostic and clinical factors. Phospho-p53 seems to be the functional p53 protein and was examined for the first time in endometrial cancer. Methods 40 patients with endometrial cancer were included in the study. A control group of 20 patients with normal endometrial tissue sample…

AdultOncologymedicine.medical_specialtyNegative progesterone receptorBlotting WesternKaplan-Meier EstimateDiseaseAdenocarcinomaDisease-Free SurvivalBody Mass IndexDiabetes ComplicationsWestern blotRecurrenceInternal medicineBiomarkers TumormedicineHumansIn patientPathologicalAgedAged 80 and overmedicine.diagnostic_testbusiness.industryEndometrial cancerObstetrics and GynecologyMiddle AgedGenes p53Prognosismedicine.diseaseEndometrial NeoplasmsUp-RegulationExact testOncologyCase-Control StudiesImmunohistochemistryElectrophoresis Polyacrylamide GelFemaleTumor Suppressor Protein p53Receptors ProgesteronebusinessGynecologic Oncology
researchProduct

Temporomandibular disorders and mandibular vertical asymmetry

2018

Objective To analyze the association between mandibular vertical asymmetry and the presence of TMD in adult patients.Methods This case-control study recruited patients from the orthodontic clinic a...

AdultOrthodonticsbusiness.industrymedia_common.quotation_subjectMandibular CondyleMandible030206 dentistryTemporomandibular Joint DisordersAsymmetrystomatognathic diseases03 medical and health sciences0302 clinical medicinestomatognathic systemOtorhinolaryngologyCase-Control StudiesRadiography PanoramicHumansMedicinebusinesshuman activitiesGeneral Dentistry030217 neurology & neurosurgerymedia_commonCRANIO®
researchProduct

Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat

2008

Abstract Objective To determine which adipocytokines are differentially expressed as a function of body mass index (BMI), to compare expression of adipocytokines in abdominal subcutaneous and omental fat, and to correlate these findings with serum levels, BMI, and parameters of insulin resistance. Methods Serum and subcutaneous (sc) and omental (om) tissue were obtained from lean and obese ovulatory women undergoing gynecologic surgery. We determined adipocytokine expression in sc versus om abdominal fat and related this to increasing BMI. Results Serum leptin was higher and adiponectin lower in overweight subjects. Adipocytokines had higher expression in sc abdominal versus om adipose tiss…

AdultOvulationmedicine.medical_specialtySettore MED/09 - Medicina InternaAdipokineAdipose tissueIntra-Abdominal FatOverweightBody Mass IndexSettore MED/13 - EndocrinologiaInsulin resistanceAdipokinesADIPONECTIN OBESITY LEPTIN CARDIOVASCULAR RISK PCOS HYPERANDROGENISMInternal medicineHumansMedicineAdiposityAdiponectinbusiness.industryLeptinnutritional and metabolic diseasesObstetrics and GynecologyGeneral Medicinemedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaObesitySubcutaneous Fat AbdominalEndocrinologyCase-Control StudiesFemaleInsulin Resistancemedicine.symptombusinessBody mass indexhormones hormone substitutes and hormone antagonistsInternational Journal of Gynecology & Obstetrics
researchProduct

Does ovarian blood flow distinguish between ovulatory and anovulatory patients with polycystic ovary syndrome?

2003

The purpose of this study was to determine whether parameters of ovarian blood flow distinguish between women with polycystic ovary syndrome (PCOS) who ovulate and those who are anovulatory.This was a prospectively enrolled trial, carried out as a cross-sectional comparison of 12 ovulatory patients with PCOS and 20 matched subjects with classic PCOS and 10 healthy control subjects. Hormonal parameters and ovarian blood flow by color flow Doppler imaging were obtained in the early follicular phase.Characteristic elevations in luteinizing hormone (LH) and androgens were found in both groups with PCOS compared with control groups. Women with anovulatory PCOS had high insulin levels and lower Q…

AdultOvulationmedicine.medical_specialtyendocrine system diseasesmedia_common.quotation_subjectHemodynamicsOvaryAnovulationDiagnosis DifferentialInsulin resistanceInternal medicinemedicineHumansInsulinProspective StudiesOvulationmedia_commonUltrasonographybusiness.industryOvaryCase-control studyObstetrics and GynecologyLuteinizing Hormonemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsEndocrinologymedicine.anatomical_structureCross-Sectional StudiesRegional Blood FlowCase-Control StudiesAndrogensFemaleInsulin ResistancebusinessLuteinizing hormoneAnovulationPolycystic Ovary SyndromeAmerican journal of obstetrics and gynecology
researchProduct